Geode Capital Management LLC Boosts Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Geode Capital Management LLC boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.3% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,112,503 shares of the company’s stock after acquiring an additional 37,159 shares during the period. Geode Capital Management LLC’s holdings in GE HealthCare Technologies were worth $989,673,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Allstate Corp grew its stake in GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock valued at $2,681,000 after acquiring an additional 16,365 shares in the last quarter. Temasek Holdings Private Ltd purchased a new position in GE HealthCare Technologies during the third quarter valued at $99,922,000. Nan Fung Trinity HK Ltd. purchased a new position in GE HealthCare Technologies during the third quarter valued at $23,206,000. Envestnet Asset Management Inc. grew its stake in GE HealthCare Technologies by 15.8% during the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock valued at $25,452,000 after acquiring an additional 46,231 shares in the last quarter. Finally, Sound Shore Management Inc CT grew its stake in shares of GE HealthCare Technologies by 14.6% in the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock worth $73,655,000 after buying an additional 125,062 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at GE HealthCare Technologies

In related news, Director Kevin Lobo acquired 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 22nd. The stock was bought at an average price of $64.18 per share, for a total transaction of $641,800.00. Following the acquisition, the director directly owned 14,363 shares of the company’s stock, valued at $921,817.34. This represents a 229.20% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Peter J. Arduini acquired 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The shares were bought at an average price of $59.92 per share, with a total value of $249,806.48. Following the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased a total of 21,847 shares of company stock worth $1,361,355 over the last ninety days. 0.36% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have commented on GEHC shares. Rothschild & Co Redburn dropped their price objective on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Barclays dropped their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a research note on Thursday, April 30th. Piper Sandler dropped their price objective on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research note on Thursday, April 30th. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Finally, Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $80.21.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $62.34 on Friday. The firm has a 50-day moving average price of $67.68 and a 200-day moving average price of $75.86. The firm has a market capitalization of $28.36 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 1.42 and a beta of 0.74. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.